Skip to Content

Tag: Coram


Also Noted

Coram downsizes in NY 

August 2, 2022HME News Staff

ALBANY, N.Y. – Coram, a subsidiary of CVS, is closing its office in Colonie, N.Y., according to the Times Union. The company has notified the state Department of Labor that it will close the office in September, resulting in the loss of 70 jobs. A spokeswoman told the newspaper that Coram has decided to scale back its services to focus on specialty medications. "We regularly review operations to focus resources as efficiently as possible and pivot when necessary to invest in health care services...

Coram, CVS, Home Infusion


Read Full Articlered right arrow icon

Also Noted

Coram's Wanda Rogers receives Gene Graves Award

March 13, 2019HME News Staff

ALEXANDRIA, Va. - The National Home Infusion Association has named Wanda Rogers the recipient of the 2019 Gene Graves Lifetime Achievement Award. Rogers is the national director of pharmacy for Coram CVS Specialty Infusion Services. Rogers serves on the NHIA Standard Committee and the Joint Commission Medication Compounding Advisory Panel, and as the regional past president of the Virginia Society of Health-Systems Pharmacists. “NHIA is proud to recognize Wanda's accomplishments and distinguished...

2019, Coram, Gene Graves Lifetime Achievement Award, National Home Infusion Association (NHIA)


Read Full Articlered right arrow icon

Also Noted

Short takes: Coram, Coloplast

April 4, 2017HME News Staff

Coram CVS Specialty Infusion Serviceshas made Functional Formularies feeding tube and oral meal replacement formulas available to its customer base. Liquid Hope and Nourish, adult and pediatric certified organic, whole foods formulas, will be available through Coram, making them even more accessible to thousands of individuals and families coping with a wide-range of challenging health conditions, from cancer to ALS, Parkinson's and MS. “Our new partnership with Coram shows the industry, which...

Coloplast, Coram, Enteral Nutrition, Wound Care


Read Full Articlered right arrow icon

Also Noted

CVS touts infusion care at home

May 6, 2016HME News Staff

WOONSOCKET, R.I. - Home infusion care is safe and clinically effective, and improves quality of life, all the while reducing costs, according to a new study by CVS Health Research Institute that has been published in Healthcare: The Journal of Delivery Science and Innovation. “As the U.S. healthcare payment system shifts from volume to value, we are focused on identifying new approaches to health service delivery that provide better care and improve patient outcomes, while lowering costs,”...

Coram, CVS, Home Infusion, Research


Read Full Articlered right arrow icon

Also Noted

Is Blackstone shopping Apria?

November 7, 2014HME News Staff

LAKE FOREST, Calif. - Private equity firm The Blackstone Group is said to be in discussions to sell Apria Healthcare, according to an article published on Reuters PE Hub. Blackstone acquired Apria in 2008 for $1.6 billion. In late 2013, Apria sold Coram, its home infusion business, to CVS Caremark for $2.1 billion. The infusion business had revenues of $975.3 million in the third quarter of 2013—about 53% of Apria's revenue.

Coram


Read Full Articlered right arrow icon

Specialty Providers

Private equity has appetite for home infusion

January 15, 2014Theresa Flaherty, Managing Editor

YARMOUTH, Maine - Demand for home infusion companies at both ends of the scale was strong in 2013, say analysts.“There's bigger deals and then there's the bolt-on acquisitions,” said Reg Blackburn, managing director of specialty pharmacy and infusion services for The Braff Group. “There's not a lot in the middle.”The big news in 2013 was the sale of Coram to CVS Caremark in November for $2.1 billion. Other notable deals include BioScrip's acquisitions of CarePoint Partners...

AxelaCare, CarePoint Partners, Coram, Home Infusion


Read Full Articlered right arrow icon

Providers

Apria ready for new 'world,' analysts say

December 6, 2013Theresa Flaherty, Managing Editor

LAKE FOREST, Calif. - Apria Healthcare has repositioned itself as a respiratory-focused company with the sale of its home infusion business, Coram, to CVS Caremark, analysts say.“My guess is that they perceive themselves as pretty well-positioned for a world of lower reimbursements and fewer competitors,” said Rick Glass, president of Steven Richards & Associates. “They have scale and run an efficient business.”The $2.1 billion deal, announced Nov. 27, allows Apria to reduce...

Apria, Competitive Bidding, Coram, Jonathan Sadock, Rick Glass


Read Full Articlered right arrow icon

Also Noted

Former Apria exec moves to new post

December 2, 2013HME News Staff

DENVER - Daniel Greenleaf is now president and CEO of specialty-infusion company Home Solutions, the Denver Post reports. “His strong executive skills and commercial and operations background bring crucial elements to achieve significant growth, operational efficiencies and continued success for Home Solutions,” said Steve Neumann, managing partner of KRG Capital Partners. Greenleaf joined Apria as president of Coram Specialty Infusion in 2008, which CVS Caremark purchased last week...

Apria, Coram, CVS, Dan Greenleaf, Home Solutions


Read Full Articlered right arrow icon

Providers

CVS buys Coram

November 27, 2013HME News Staff

LAKE FOREST, Calif. - CVS Caremark has agreed to acquire Apria's home infusion business, Coram, for $2.1 billion, the companies announced today. “CVS Caremark and Coram share a mutual commitment to provide patients with quality care,” said John Figueroa, Coram CEO. Apria acquired Denver-based Coram for $350 million in 2007. Today, Coram has more than 4,500 employees and serves more than 20,000 patients each month through 85 locations. Third quarter revenues for the division,...

Coram, CVS Caremark, Home Infusion, Option Care


Read Full Articlered right arrow icon